Beyond the Abstract - The Use of Urovysion™ Fluorescence In Situ Hybridization in the Diagnosis and Surveillance of Non-Urothelial Carcinoma of the Bladder
BERKELEY, CA (UroToday.com) - Urothelial carcinoma accounts for 90-95% of bladder cancers in the Western hemisphere.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |





